Search results for "C25"

showing 10 items of 566 documents

Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcino…

2020

Background: Systemic chemotherapy for pancreatic adenocarcinoma (PDAC) and cholangiocarcinoma (CC) with peritoneal metastases (PM) is affected by several pharmacological shortcomings and low clinical efficacy. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is expected to maximize exposure of peritoneal nodules to antiblastic agents. This study aims to evaluate safety and efficacy of PIPAC for PM of PDAC and CC origin. Methods: This is a retrospective analysis of consecutive PDAC and CC cases with PM treated with PIPAC at two European referral centers for peritoneal disease. We prospectively recorded from August 2016 to May 2019 demographic, clinical, surgical, and oncological data…

Peritoneal metastasismedicine.medical_treatmentSettore MED/18 - CHIRURGIA GENERALEpancreatic cancerPIPACcarcinomatosislcsh:RC254-282Pancreatic cancerMedicineDoxorubicincarcinomatosiOriginal ResearchCisplatinChemotherapybusiness.industrySystemic chemotherapyperitoneal metastaseaerosol chemotherapymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensdigestive system diseasesOxaliplatinperitoneal metastasesOncologyCancer researchlocoregional chemotherapyAdenocarcinomaPIPAC.businesscholangiocarcinomamedicine.drugTherapeutic Advances in Medical Oncology
researchProduct

Editorial debate: Challenges we oncologists, working within a universal healthcare system, have to face in these hard times

2020

I have been very much impressed by the clarity, pragmatism and good medical judgement of the article by Camilo Porta,1 a respected and dedicated ESMO faculty member and friend, giving his personal perspective on real issues many oncologists working in a public system are eventually facing during the SARS-CoV-2 pandemic. I understand Professor Porta is voicing what many oncologists from countries deeply affected by the pandemic, such as Italy or Spain, may think. Although I concur with most of his approaches and comments, I would like to complement some of these statements with some additional thoughts. Medicine was created more than 2500 years ago as a profession aiming at alleviating suffe…

PragmatismCancer Researchbusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)media_common.quotation_subjectPerspective (graphical)JudgementFace (sociological concept)Public relationslcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282law.inventionOncologylawPolitical sciencePandemicCLARITYbusinessmedia_commonHealthcare systemESMO Open
researchProduct

Predictores de duelo complicado

2008

Pilar.Barreto@uv.es; Patricia.Yi@uv.es OBJETIVO: Estudiar el proceso de evolución en sus primeras etapas tras la pérdida y determinar cuáles son los factores de riesgo y protección previos a la muerte que permiten predecir el surgimiento de posibles complicaciones en los familiares/cuidadores de pacientes oncológicos. MÉTODO: Se evaluaron 236 dolientes cuyos familiares eran pacientes oncológicos atendidos en servicios de cuidados paliativos de Valencia y Madrid y se realizó un seguimiento en 2 momentos temporales: 2 y 6 meses tras la muerte, evaluándose la presencia/ausencia de complicaciones en el proceso de duelo mediante dos criterios diagnósticos (DSM e ICG). RESULTADOS: Se encontró una…

Predicción de duelo complicadoProtectoreslcsh:BF1-990Protectors:PSICOLOGÍA::Asesoramiento y orientación ::Orientación profesional [UNESCO]lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensDuelolcsh:RC254-282lcsh:PsychologyGrief developmentRisk factorsPrediction of complicated bereavementDuelo; Evolución de la pena; Factores de riesgo; Protectores; Predicción de duelo complicadoUNESCO::PSICOLOGÍA::Asesoramiento y orientación ::Orientación profesionalEvolución de la penaBereavementFactores de riesgoPsicooncologia
researchProduct

On Cancer Cell Cycle and Universal Apoptosis Parameters Signaling Unravelled In Silico

2010

Here, cell cycle in higher eukaryotes and their molecular networks signals both in G1/S and G2/M transitions are in silico replicated. Systems control theory is employed to design multi-nestled digital layers to simulate protein-to- protein activation and inhibition in the cancer cell cycle dynamics in presence of damaged genome. Sequencing and controlling the digital process of four micro-scale species networks (p53/Mdm2/DNA damage; p21mRNA/cyclin-CDK complex; CDK/CDC25/wee1/SKP2/APC/CKI and apoptosis target genes system) paved the way for unravelling the participants and their by-products having the task to execute (or not) cell death. The results of the proposed cell digital multi-layers…

Programmed cell deathWee1Cell signalingCell cycle checkpointbiologyCdc25Cyclin-dependent kinaseIn silicobiology.proteinCell cycleCell biologyThe Open Conference Proceedings Journal
researchProduct

Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by KRAS Mutation Subtypes

2020

Abstract Introduction KRAS mutations are detected in 20% to 30% of NSCLC. However, KRAS mutation subtypes may differently influence the outcome of patients with advanced NSCLC. Methods In the Biomarkers France study, 4894 KRAS mutations (26.2%) were detected in 4634 patients from the 17,664 enrolled patients with NSCLC. Survival and treatment data on noncurative stage III to IV NSCLC were available for 901 patients. First- and second-line treatment effects on progression-free survival and overall survival were analyzed according to the KRAS mutations subtype. Results Over 95% of patients with KRAS mutation were smokers or former smokers who were white (99.5%), presenting with adenocarcinoma…

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyendocrine system diseases[SDV.CAN]Life Sciences [q-bio]/Cancermedicine.disease_causeNSCLClcsh:RC254-28203 medical and health sciences0302 clinical medicine[SDV.CAN] Life Sciences [q-bio]/CancerNon-small cell lung cancerInternal medicinemedicineOverall survivalNon–small cell lung cancerStage (cooking)neoplasms030304 developmental biology0303 health sciencesMutationTransition (genetics)business.industryKRAS mutationmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrognosisConfidence intervaldigestive system diseases3. Good healthrespiratory tract diseasesOncology030220 oncology & carcinogenesisAdenocarcinomaOriginal ArticleKRASbusinessKras mutation
researchProduct

Existence of common zeros for commuting vector fields on 3‐manifolds II. Solving global difficulties

2020

We address the following conjecture about the existence of common zeros for commuting vector fields in dimension three: if $X,Y$ are two $C^1$ commuting vector fields on a $3$-manifold $M$, and $U$ is a relatively compact open such that $X$ does not vanish on the boundary of $U$ and has a non vanishing Poincar\'e-Hopf index in $U$, then $X$ and $Y$ have a common zero inside $U$. We prove this conjecture when $X$ and $Y$ are of class $C^3$ and every periodic orbit of $Y$ along which $X$ and $Y$ are collinear is partially hyperbolic. We also prove the conjecture, still in the $C^3$ setting, assuming that the flow $Y$ leaves invariant a transverse plane field. These results shed new light on t…

Pure mathematicsConjectureGeneral Mathematics37C85010102 general mathematicsZero (complex analysis)Boundary (topology)Field (mathematics)Dynamical Systems (math.DS)01 natural sciences37C25Flow (mathematics)Relatively compact subspace0103 physical sciences58C30 (primary)FOS: MathematicsVector field010307 mathematical physics0101 mathematicsInvariant (mathematics)Mathematics - Dynamical Systems[MATH]Mathematics [math]57S05Mathematics
researchProduct

On the existence of attractors

2009

On every compact 3-manifold, we build a non-empty open set $\cU$ of $\Diff^1(M)$ such that, for every $r\geq 1$, every $C^r$-generic diffeomorphism $f\in\cU\cap \Diff^r(M)$ has no topological attractors. On higher dimensional manifolds, one may require that $f$ has neither topological attractors nor topological repellers. Our examples have finitely many quasi attractors. For flows, we may require that these quasi attractors contain singular points. Finally we discuss alternative definitions of attractors which may be better adapted to generic dynamics.

Pure mathematicsMathematics::Dynamical SystemsApplied MathematicsGeneral MathematicsMathematical analysisOpen setDynamical Systems (math.DS)Nonlinear Sciences::Chaotic Dynamics37C05 37C20 37C25 37C29 37D30AttractorFOS: MathematicsDiffeomorphismMathematics - Dynamical SystemsMathematics::Symplectic GeometryMathematics
researchProduct

Heterogeneity in general practitioners’ preferences for quality improvement programs: a choice experiment and policy simulation in France

2016

International audience; Despite increasing popularity, quality improvement programs (QIP) have had modest and variable impacts on enhancing the quality of physician practice. We investigate the heterogeneity of physicians’ preferences as a potential explanation of these mixed results in France, where the national voluntary QIP – the CAPI – has been cancelled due to its unpopularity. We rely on a discrete choice experiment to elicit heterogeneity in physicians’ preferences for the financial and non-financial components of QIP. Using mixed and latent class logit models, results show that the two models should be used in concert to shed light on different aspects of the heterogeneity in prefer…

Quality managementmedia_common.quotation_subjectLogit03 medical and health sciences0302 clinical medicineMixed logitGeneral practitionersddc:330Economics[ SHS.ECO ] Humanities and Social Sciences/Economies and financesQuality (business)030212 general & internal medicineLatent class logitPreference (economics)media_commonActuarial scienceI18I11030503 health policy & servicesHealth PolicyResearchUnpopularityPolicy simulation[SHS.ECO]Humanities and Social Sciences/Economics and FinancePopularityLatent class modelDiscrete choice experimentC25Mixed logit0305 other medical scienceQuality improvement programsHealth Economics Review
researchProduct

Management of Spinal Bone Metastases With Radiofrequency Ablation, Vertebral Reinforcement and Transpedicular Fixation: A Retrospective Single-Center…

2022

Spine is a frequent site of bone metastases, with a 8.5 months median survival time after diagnosis. In most cases treatment is only palliative. Several advanced techniques can ensure a better Quality of Life (QoL) and increase life expectancy. Radiofrequency ablation (RFA) uses alternating current to produce local heating and necrosis of the spinal lesion, preserving the healthy bone. RFA is supported by vertebral reinforcement through kyphoplasty and vertebroplasty in order to stabilize the fracture with polymethylmethacrylate (PMMA) injection, restoring vertebral body height and reducing the weakness of healthy bone. The aim of this study is to demonstrate the efficacy and advantages of …

RFACancer Researchvertebral reinforcementOncologySettore MED/27 - NeurochirurgiaNeoplasms. Tumors. Oncology. Including cancer and carcinogensspinal fixationPMMARC254-282Original Researchspinal metastasesFrontiers in oncology
researchProduct

La realidad virtual en las intervenciones psicológicas con pacientes oncológicos

2014

El objetivo de este trabajo es presentar las principales aportaciones de la Realidad Virtual (RV) en el tratamiento psicologico con pacientes oncologicos, y describir un programa de intervencion que utiliza esta tecnologia para promover bienestar emocional en pacientes hospitalizados. La RV se presenta como una prometedora herramienta de apoyo al paciente oncologico. Diversos estudios plantean su utilidad para hacer algunos tratamientos medicos mas tolerables, para reducir los niveles de distres y dolor, asi como promover mayores niveles de emociones positivas. Se ha empleado principalmente con pacientes ambulatorios, existiendo una menor proporcion de propuestas dirigidas al periodo de hos…

Realidad virtualClinical Psychologylcsh:PsychologyOncologycáncerdistréslcsh:BF1-990lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282bienestar emocional.Psicooncologia
researchProduct